Symptoms include severe abdominal pain, nausea, vomiting, and fever
SURPASS-2 directly compared tirzepatide (5 mg, 10 mg, and 15 mg weekly) against semaglutide 1 mg weekly, demonstrating HbA1c reductions of 2.01% (22 mmol/mol), 2.24% (24 mmol/mol), and 2.30% (25 mmol/mol) respectively, versus 1.86% (20 mmol/mol) with semaglutide
Ozempic isalso approved to reduce the risk of heart attack, stroke, or death in adultswith type 2 diabetes mellitus and known heart disease.Wegovy injectionis approved to help adults and children aged 12 years and older with obesity orsome adults with excess weight (overweight), who also have weight-relatedmedical problems, to lose weight and keep the weight off, in addition to dietand exercise
A compounded path uses medication a licensed pharmacy prepares, and compounded medication is not FDA-approved
Discuss the best options for your specific situation with your endocrinologist and maternal-fetal medicine specialist